Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.
- 23 October 2001
- journal article
- clinical trial
- Published by Wiley in Journal of Medical Virology
- Vol. 65 (4) , 681-687
- https://doi.org/10.1002/jmv.2090
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor populationLiver Transplantation, 2001
- De novo and apparent de novo hepatitis B virus infection after liver transplantationJournal of Hepatology, 1997
- Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liverJournal of Hepatology, 1997
- A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis CJournal of Hepatology, 1996
- Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response ratesJournal of Hepatology, 1995
- Factors predictive of the response to interferon in patients with chronic hepatitis CJournal of Hepatology, 1994
- Inapparent “wild-type” and “e-minus variant” HBV infection in patients with HCV-related chronic hepatitisLiver International, 1994
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989